default author photo

Seiichi Imanishi

Osaka Rosai Hospital

Osaka

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

19

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Possibility of Human Epidermal Growth Factor Receptor 2 Expression as a Treatment Selection Indicator in Early Triple-Negative Breast Cancer

Number of pages: 17 Posted: 28 Jun 2024
Osaka Rosai Hospital, Osaka Rosai Hospital, Osaka Rosai Hospital, Osaka Rosai Hospital and Osaka Rosai Hospital
Downloads 19 (1,459,862)

Abstract:

Loading...

early triple-negative breast cancer, human epidermal growth factor receptor 2, neoadjuvant chemotherapy, prognosis, immune checkpoint inhibitor